Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Lymphoma, B-Cell × cemiplimab × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Melanoma 3 Carcinoma, Squamous Cell 3 Recurrence 2 Lung Neoplasms 2 Resectable Non-small Cell Lung Cancer 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Motor Activity 1 Lymphoma, B-Cell 1 Laryngeal Neoplasms 1 Invasive Breast Cancer 1 Hypopharyngeal Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Glioblastoma 1 Cutaneous Squamous Cell Carcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Advanced Non-small Cell Lung Cancer 1 Advanced Non-Small Cell Lung Cancer 1 Advanced Malignancies 1

Interventions

Cyclophosphamide 17 Rituximab 13 fludarabine 8 Prednisone 6 Lenalidomide 6 Doxorubicin 6 pirtobrutinib 5 fludarabine phosphate 5 Vincristine 5 Bendamustine Hydrochloride 5 venetoclax 4 Etoposide 4 CT-P10 4 polatuzumab vedotin 3 pembrolizumab 3 ibrutinib 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Immunotherapy, Adoptive 3 liposomal doxorubicin 2 etoposide phosphate 2 acalabrutinib 2 Nivolumab 2 Injections 2 Biopsy 2 zanubrutinib 1 varlilumab 1 tocilizumab 1 tisagenlecleucel 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02651662 2026-02-02

CLIO-1

Regeneron Pharmaceuticals

Phase 1 Active not recruiting

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡